
GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …
Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …
A round-up of recent developments in the contract research sector, including KKR’s acquisition of PRA, a new Parexel business unit …

Biopharma services provider PAREXEL has appointed Ingo Bank to be a senior VP and chief financial officer at the firm. …
Catalent Pharma Solutions has formed an alliance with Parexel in a further boost to its aspirations in clinical trial material …
Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …
Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in …

Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …
Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …
Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …
A round-up of recent news from the CRO sector, featuring updates from CIT, Parexel, PPD, Cardialysis/Sticares and Porsolt. French non-clinical …
Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …
Developments in the contract research sector this week include the opening of new offices for Parexel and PPD, the spin-out …
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …